- Published:
Experimental Vaccination of Pigs with an Actinobacillus pleuropneumoniae Serotype 5b Capsular Polysaccharide-Tetanus Toxoid Conjugate
Acta Veterinaria Scandinavica volume 38, pages 283–293 (1997)
Abstract
The protective efficacy of an Actinobacillus pleuropneumoniae serotype 5b capsular polysaccharide-tetanus toxoid conjugate (Ap5bCP-TT) against homologous challenge of pigs was investigated. Four pigs were non-vaccinated controls (group A), 4 pigs were injected with adjuvant without antigen (group B) and 8 pigs were vaccinated with Ap5bCP-TT and adjuvant (group C). Pigs vaccinated with Ap5bCP-TT developed antibody responses to the capsular polysaccharide from A. pleuropneumoniae serotype 5b (Ap5bCP). After challenge, all pigs in groups A and B had severe clinical signs of disease and were euthanized. In group C, 3 out of 8 pigs showed severe symptoms and were euthanized. Five pigs in group C survived throughout the study. The post challenge observation period was 72 h. All pigs were subject to necropsy and results from gross pathological findings and microbiological examination are described. Pigs vaccinated with Ap5bCP-TT had statistically significant reduced values of the mass ratio of affected to unaffected lung tissue compared to pigs in groups A and B (p = 0.01 and p = 0.007, respectively). The results showed that Ap5bCP-TT-vaccination had considerable protective efficacy against lethality and pulmonary lesions caused by experimental infection with A. pleuropneumoniae serotype 5b.
References
Bosch JFvd, Pennings AMMA, Cuijpers MECM, Pubben ANB, Vugt FGAv, Liden MFIvd: Heterologous protection induced by an A. pleuropneumoniae subunit vaccine. Proc. 11th Int. Pig Vet. Soc. Congress, Switzerland 1990, p.11.
Bosch JFvd, Jogenelen IMCA, Pubben ANB, Vugt FGA, Segers RPAM: Protection induced by a tri-valent A. pleuropneumoniae subunit vaccine. Proc. 12th Int. Pig Vet. Soc. Congress, The Netherlands 1992, p. 194.
Byrd W, Harmon BG, Kadis S: Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae. Vet. Immunol. Immunopathol., 1992, 34, 307–324.
Byrd W, Kadis S: Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants. Infect. Immun., 1992, 60, 3042–3051.
Desrosiers R, Mittal KR, Malo R: Porcine pleuropneumonia associated with Haemophilus pleuropneumoniae serotype 3 in Quebec. Vet. Rec., 1984, 115, 628–629.
Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F: Colorimetric method for determination of sugars and related substances. Analytical Chemistry, 1956, 28, 350–356.
Fattom A, Schneerson R, Watson DC, Karakawa WW Fitzgerald D, Pastan I, Li X, Shiloach J, Bryla DA, Robbins JB: Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect. Immun., 1993, 61, 1023–1032.
Fedorka-Cray PJ, Huether MJ, Stine DL, Anderson GA: Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine. Infect. Immun., 1990, 58, 358–365.
Frey J, Bosse JT, Chang Y-F, Cullen JM, Fenwick B, Gerlach GF, Gygi D, Haesebrouck F, Inzana TJ, Jansen R, Kamp EM, Macdonald J, Macinnes JI, Mittal KR, Nicolet J, Rycroft AN, Segers RPAM, Smits MA, Stenbaek E, Struck DK, Bosch JFvd, Willson PJ, Young R: Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of hae-molysins, cytolysins, pleurotoxin and their genes. J. Gen. Microbiol., 1993, 139, 1723–1728.
Gray GR: Antibodies to carbohydrates: Preparation of antigens by coupling carbohydrates to proteins by reductive amination with cyanoborohydride. Methods inEnzymology, 1978, 50, 155–160.
Higgins R, Larivière S, Mittal KR, Martineau GP, Rousseau P, Cameron J: Evaluation of a killed vaccine against porcine pleuropneumonia due to Haemophilus pleuropneumoniae. Can. Vet. J., 1985, 26, 86–89.
Inzana TJ, Ma J, Workman T, Gogolewski RP, Anderson P: Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype. Infect. Immun., 1988, 56, 1880–1889.
Inzana TJ, Todd J, Veit HP: Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines. Infect. Immun., 1993, 61, 1682–1686.
Jacobsen MJ, Nielsen JP: Development of a selective and indicative medium for isolation of Actinobacillus pleuropneumoniae from tonsils. Vet. Microbiol., 1995, 47, 191–197.
Jacobsen MJ, Nielsen JP, Nielsen R: Comparison of virulence of different Actinobacillus pleuropneumoniae serotypes and biotypes using an aerosol infection model. Vet. Microbiol. 1995, 49, 159–168.
Kamp EM, Vermulen TMM, Cruysen T, Dijk JEv, Rie-pema K, Smits MA, Leeuwen JMv: Actinobacillus pleuropneumoniae cytolysins: Gross protective effect of a crude cytolysin-vaccine. Proc. 12th Int. Pig Vet. Soc. Congress, The Netherlands 1992, p.209.
Nicolet J: Sur l’hémophilose du pore. III. Differenci-ation sérologique de Haemophilus parahaemolyt-icus. Zentralbl. Bakteriol. Abt. 1 Orig., 1971, 216, 487–495.
Nicolet J: Actinobacillus pleuropneumoniae. In: Le-man AD, Straw BE, Mengeling WL, D’Allaire S, Taylor DJ (eds): Diseases of Swine. 7th ed. Wolfe Publishing Ltd., Ames 1992, p. 401–418.
Nielsen R: Pleuropneumoniae of swine caused by Haemophilus parahaemolyticus studies on the protection obtained by vaccination. Nord. Vet.-Med., 1976, 28, 337–348.
Nielsen R: Haemophilus pleuropneumoniae infection in pigs. Carl Fr. Mortensen A/S, Copenhagen, 1982.
Nielsen R: Haemophilus pleuropneumonias serotypes–cross protection experiments. Nord. Vet-Med. 1984, 36, 221–234.
Nielsen R: New diagnostic techniques: a review of the HAP group of bacteria. Can. J. Vet. Res. 1990, 54, S68–S72.
Nielsen R, Andresen LO, Plambeck T: Serological characterization of Actinobacillus pleuropneumoniae biotype 1 strains antigenically related to both serotypes 2 and 7. Acta Vet. Scand., 1996, 37, 327–336.
Nielsen R., Andresen LO, Plambeck T, Nielsen JP, Krarup LT, Jorsal SE: Serological characterization of Actinobacillus pleuropneumoniae biotype 2 strains isolated from pigs in two Danish herds. Vet. Microbiol., 1997, 54, 35–46.
Peeters CCAM, Tenbergen-Meekes A-M, Haagmans B, Evenberg D, Poolman JT, Zegers BJM, Rijkers GT: Pneumococcal conjugate vaccines. Immunol. Lett., 1991, 30, 267–274.
Perry MB, Altman E, Brisson J-R, Beynon LM, Richards JC: Structural characteristics of the antigenic capsular polysaccharides and lipopolysac-charides involved in the serological classification of Actinobacillus (Haemophilus) pleuropneu-moniae strains. Serodiagnosis and Immunotherapy in Infectious Diseases, 1990, 4, 299–308.
Robbins JB, Schneerson R: Polysaccharide-protein conjugates: A new generation of vaccines. J. Infect. Dis., 1990, 161, 821–832.
Rosendal S, Miniats OP, Sinclair P: Protective efficacy of capsule extracts of Haemophilus pleurop-neumoniae in pigs and mice. Vet. Microbiol., 1986, 12, 229–240.
Rossi-Campos A, Anderson C, Gerlach GF, Klashin-sky S, Potter AA, Willson PJ: Immunization of pigs against Actinobacillus pleuropneumoniae with 2 recombinant protein preparations. Vaccine, 1992, 10, 512–518.
Schneerson R, Robbins JB, Parke JCJ, Bell C, Schles-selman J J, Sutton A, Wang Z, Schiffman G, Kar-pas A, Shiloach J: Quantitative and qualitative analysis of serum antibodies elicted in adults by Haemophilus influenzae type b and Pneumococ-cus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect. Immun. 1986, 52, 519–528.
Schneerson R, Levi L, Robbins JB, Bryla DM, Schiffman G, Lagergard T: Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin. Infect. Immun., 1992, 60, 3528–3532.
Sebunya TNK, Saunders JR: Haemophilus pleuropneumoniae infection in swine: A review. J. Am. Vet. Med. Assoc. 1983, 182, 1331–1337.
Shope RE: Porcine contagious pleuropneumonia I. Experimental transmission, etiology, and pathology. J. Exp. Med., 1964, 119, 357–368.
Smits M, Kamp E, Briaire J, Jansen R, Leegoed Lv, Dijk Jv: Induction of pneumonic lesions by recombinant cytolysins of Actinobacillus pleuropneumoniae.. Proc. 12th Int. Pig Vet. Soc. Congress, The Netherlands 1992, p. 187. Sorensen UBS, Blom J, Birch-Andersen A, Henrich-sen J: Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci. Infect. Immun., 1988, 56, 1890–1896.
Acknowledgment
This work was supported by the National Committee for Pig Breeding, Health and Production, Federation of Danish Pig Producers and Slaughterhouses. We wish to thank Mrs. Heidi P. Andersen and Mrs. Birgit H. Christensen for skillful technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andresen, L.O., Jacobsen, M.J. & Nielsen, J.P. Experimental Vaccination of Pigs with an Actinobacillus pleuropneumoniae Serotype 5b Capsular Polysaccharide-Tetanus Toxoid Conjugate. Acta Vet Scand 38, 283–293 (1997). https://doi.org/10.1186/BF03548491
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03548491